Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

From Alzheimer's prevention to weight-loss dominance, Novo bets on innovation and share repurchases amid Medicare pressure.

Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price ...

A letter from several Democratic Senators urged Trump to use his deal-making skills to “flat out reject any request to end ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

A group of lawmakers are urging President Donald Trump to reject pharmaceutical companies’ efforts to pause the Biden ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

The founder, managing principal, and chief investment officer of AQR Capital Management, […] Eli Lilly and Company ( NYSE:LLY ) will increase its dividend from last year's comparable payment on the ...

Medicare’s $35 insulin price cap was signed ... In 2023, insulin manufacturer Eli Lilly voluntarily capped out-of-pocket costs for its insulin at $35 at participating pharmacies for people ...